News and Events

18 September 2024

Determination of total bound iron in human blood serum samples

Ironing out the challenges: measuring total bound iron in blood serum in Ferric Carboxymaltose (FCM) Studies

4 September 2024

Meet us at the heart of Pharma at CPHI 2024

As a part of Conscio Group, we are attending CPHI 2024 in Milan, Italy.

18 March 2024

News from our newly opened clinic in Ostrava

Our new Clinic in Ostrava (CZ) is gaining momentum step by step; therefore, we have some interesting news for you from the center of the action.

19 December 2023

Happy new year 2024

As we bid farewell to 2023, it's time to express our deepest gratitude for the collaboration.

4 December 2023

Our new clinical unit in Ostrava comes to life

It's a great pleasure to announce that after two years of hard work, the brand-new clinical unit in Ostrava with 36-beds capacity has been opened.

3 October 2023

Meet us at the heart of Pharma, CPHI 2023

Quinta-Analytica is attending CPHI 2023 in Barcelona

18 July 2023

Challenges of a large-scale study of breast cancer

Our bioanalytical experts and a high-profile client team up for the development of a new therapy for breast cancer.

29 June 2023

EU funding for Quinta-Analytica laboratory in Brno (CZ) was succesfully completed.

After two years, the project to finance new equipment for the Quinta-Analytica laboratory in Brno was successfully completed. The investment from European Regional Development Fund was used in this project.

22 June 2023

Quinta Analytica Partners with EvidentIQ to Enhance Efficiency of Phase 1 Studies

EvidentIQ partners with Quinta-Analytica to enhance Phase 1 study efficiency

15 June 2023

Novavax & Conscio: Behind the Scenes of Vaccine Development

Discover how the Conscio Group and renowned vaccine manufacturer Novavax collaborate behind the scenes to ensure quality and efficiency in vaccine production.

8 June 2023

Ekolab And Conscio Group Join Forces

Ekolab joins the Conscio Group, enhancing our analytical capabilities and solidifying our position in pharmaceutical, nutrition, and technology solutions.

8 June 2023

Clinical Tips – Drug Interactions in Advanced Clinical Trial Design

Drug interactions play a key role in the design of clinical trials. Learn how we investigate such interactions when conducting pharmacokinetic/bioequivalence studies and while offering end-to-end support throughout the process.

6 April 2023

Transdermal Patches, Films and Topicals – Putting the Skin in the Game

Today we talk about novel drug delivery systems and in vitro testing techniques. Learn about our work with transdermal patches, orally dissolving films, topical products and Franz cell testing.

23 March 2023

Clinical Tips – Benefits of Sequential Designs in Bioequivalence Studies

Discover the power of sequential designs for bioequivalence studies, a crucial step in generics development: Their practical implementation, statistical analysis, and the well-being of the volunteers.

23 March 2023

A Prescription Against EU Medicine Shortages – Outsourcing Stabilities

We highlight the reasons behind current EU drug shortages and the key role CROs and outsourced stability testing play in diversifying drug production.

27 January 2023

Pharmaceutical Offshore Outsourcing in the USA: Opportunities & Misconceptions

Dr. Jeffrey Kiel, founder and CEO of Kiel Laboratories, talks about offshore outsourcing in the USA and working with Quinta-Analytica.

5 January 2023

From Houston to Munich – Innovation & Compounding

Pharma innovators often outsource demanding projects to specialist CROs. Gus Bassani of US-based PCCA and Markus Dachtler of Conscio's German subsidiary Gen-Plus, share lessons from their collaboration.

7 December 2022

Quinta’s Another Two Successful FDA Inspections

We at Quinta-Analytica are proud to announce the successful completion of not 1 but 2 FDA inspections at our Prague and Brno sites. Thanks for your trust and support!

24 November 2022

The Secret Behind 25 Years of Excellence

Quinta-Analytica's 25th Anniversary give us the chance to look back at our successful trajectory of proactiveness, technical expertise and improvement in the company of Dr Miroslav Ryska, mass spectrometry expert and founder of Quinta.

24 November 2022

Quinta-Analytica + Olga Havel Foundation – Helping to Help Others

We are proud to announce that Quinta-Analytica has donated 100,000 CZK to the Olga Havel Foundation for the support of six families with members in need of neurorehabilitation.

24 November 2022

Nitrosamine Analogues: Stepping up to a new Challenge

Have you heard about Nitrosamine Analogues? Did you know even if a tested API is free of nitrosamine analogues, its related drug product may still contain high amounts of these new impurities? Keep reading to learn more!

24 November 2022

New Stability Models for Faster & Better Shelf Life Estimations

Are you a pharma company in need of stability testing but have just too many candidates to screen with conventional ICH assays? We at Quinta-Analytica can offer you accurate stability data 3 times faster than usual! Find out more below.

24 November 2022

CPHI Frankfurt 2022: See you there!

Quinta-Analytica is attending CPHI 2022 in Frankfurt

24 November 2022

Clinical Tips: Linear & non-linear PK

QUINTA is well-known for its state-of-the-art equipment and facilities used to perform clinical trials and bioanalytical services under GCP/GLP; but today our experts wish to talk about pharmacokinetics and statistical evaluations, an important part of their day to day work which doesn't always get the attention it deserves. Click and keep reading!

24 November 2022

Clinical Tips: Intra- and Inter-subject Variability

Interested in clinical study design? Today's Clinical Tips series focuses on intra- and inter-subject variability, crucial concepts for the correct calculation of sample size.

24 November 2022

Clinical Tips: Bioequivalences with urinary data

Volunteers participating in trials at our clinical unit are sometimes surprised to discover that samples collected during the studies are not always blood but can also involve other biological fluids such as urine. Keep reading to learn more about our clinical R&D activities.

24 November 2022

ADC characterisation: When small & large molecules collide

Quinta-Analytica is among the few CROs offering GCP/GLP/GMP services for biologics. We and our valued biotech client SOTIO wish to share our experience with antibody-drug conjugates, the toughest biologics.

24 November 2022

Gen-Plus + Conscio Partnership

Today we proudly announce that Gen-Plus GmbH & Co. KG, a Munich-based pharma R&D and manufacturing expert, has become a new member of the Conscio Group.

3 November 2022

Stability Chambers

As everyone in the pharma world knows, stability testing is one of the most crucial steps in the development of new drug products.

12 May 2022

Liquid Chromatography Apparatus Just Got Even Better.‍

The introduction of Ultra-High Performance Liquid Chromatography was a significant milestone in the evolution of LC, and is certainly a very powerful tool for today’s chromatographer

4 May 2022

What are Endogenous Substances? And how can they be identified?

The bioequivalence of generic versions of certain reference drugs can often be complicated by the presence of endogenous levels of compounds, so how can you identify them?

21 April 2022

Problem Packaging. The next safety concern?‍

Prior to the release of a #pharmaceutical, it has always been necessary to determine the impurity profile of the final product, however nowadays the impurities from the components used during manufacture and storage must be also considered.

7 April 2022

Are you Ukrainian and looking for work in the Czech Republic?

Ви українець та шукаєте роботу в Чехії? | Are you Ukrainian and looking for work in the Czech Republic? | Jste z Ukrajiny a hledáte práci v České republice?

31 March 2022

Sampling Time in Pharmacokinetics. Getting it right, matters.

The design of pharmacokinetic sampling times plays a critical role in the reliability of bioequivalence evaluation, as does ensuring that enough samples are collected.

31 March 2022

In the world of science and pharmaceuticals, details matter.

Cancer biologists at a world-renowned university have developed a new piece of technology that will help researchers see cells in more precise detail

1 March 2022

New investment from BBA CapitalPartners

QUINTA-ANALYTICA are very happy to announce new investment from renowned family equity firm BBA CapitalPartners.

24 February 2022

Current Antibacterial Drug Development

Deaths caused by infectious diseases have fallen by 70% since antibiotics were introduced on a large scale in the 1940s, yet we’ve seen a significant decrease in the number of new antibiotics reaching the market and this could be an issue.

24 February 2022

Advancement For Animal Medicine

Finally, for the first time, information about all veterinary medicines authorized in the EU and European Economic Area (EEA) countries will be available on a central website.

31 January 2022

Pharmacokinetics: Complex Yet Fascinating

This key branch of pharmacology is dedicated to determining the fate of substances administered to a living organism, such as pharmaceutical drugs, pesticides, and food additives.

31 January 2022

Validating BioAnalytical Methods

The measurement of drug concentrations in biological matrices is an important aspect of medicinal product development.

31 January 2022

Thank You to our Clinical Team

When we look back at the people that kept the world turning during these difficult times, we pay our thanks to those who continued to enable drug development and safely help bring drugs to market in the quickest possible way.

31 January 2022

Immense Tasks. Incredible Teams. Ingenious Instruments.

Flagged as the next generation of ultra-performance instrumentation, the high resolution of the quaternary LC System offers a significant improvement when compared to older models.

31 January 2022

Giving Back, One Tree at a Time

With the world waking up to the effects of climate change, QUINTA-ANALYTICA have taken their own first small step this week in giving back, one tree at a time.

31 January 2022

Accelerating Clinical Trials in the EU

The European Commission, HMA, and EMA have launched an initiative to transform how clinical trials are run across the union.

29 December 2021

Announcing Conscio Pharmaceuticals

Quinta are enormously proud to announce the opening of their new, USA-based affiliate company, Conscio Pharmaceuticals Inc.

29 December 2021

Widespread use of real-world evidence in EU medicines regulation

Real-world data and real-world evidence are already used in the regulation of some medicines across the EU, but the vision is that by 2025 the use of RWE will have been fully enabled.

29 December 2021

Happy Holidays and a Joyous New Year

As the Holiday Season is upon us, we find ourselves reflecting on the past year, and what a rollercoaster it has been!

29 December 2021

Food Effect Studies

We all love to eat, but many people are unaware of the correlation between food and medicine effectiveness.

30 November 2021

Good Morning CPhI 2021, Day Two!

Following a thrilling first day in milano at the fieramilano exhibition space, CPhI gets underway for day two and the QUINTA-ANALYTICA team are fired up and raring to go.

30 November 2021

Welcome to CPhI 2021!

As CPhI Worldwide gets underway, the QUINTA-ANALYTICA team are all set up here in milan and ready to welcome you.

30 November 2021

The Rapid Expansion of AI in Pharma

With Artificial Intelligence penetrating the pharma world at a rapid pace, three regulators have joined forces with the aim of fostering Good Machine Learning Practice (GMLP).

30 November 2021

Meet Us in Milan!

Billed as the biggest pharma event of the year, CPhI 2021 is a prime opportunity to make new connections and meet the QUINTA-ANALYTICA team.

30 November 2021

CPhI Worldwide 2021 Milan

As many of us struggle to believe it’s October already, the realization of that calendar milestone also means we’re just one month away from the biggest pharma event of the year, CPhI Worldwide.

28 October 2021

Why Do We Test On Healthy Volunteers?

Bioequivalence and bioavailability studies should be conducted preferentially from a healthy volunteer population unless the drug carries safety concerns that make this unethical.

28 October 2021

Testing of Highly Variable Drugs

HVD are drugs whose within-subject variance is larger than preset regulatory bioequivalence limits. How do we properly measure and test these types of drugs?

28 October 2021

Quinta Summer Fun

In keeping with the annual tradition of celebrating the wind down from summer, the teams at QUINTA-ANALYTICA certainly let their hair down in style last Friday.

28 October 2021

Keeping Your Pets Safe

It’s not always easy to manage the array of dietary requirements, veterinary needs, and overall health of your furry, fluffy, or indeed scaly companions.

28 October 2021

Exploring Narrow Therapeutic Index Drugs

Narrow therapeutic index (NTI) drugs are defined as those drugs where small differences in dose, or concentration in the blood, may lead to serious therapeutic failures or adverse drug reactions.

28 October 2021

Brno is brimming with best-in-class equipment

It may be the Czech Republics’ second-largest city, but there’s nothing second about the knowledge and long-term experience of dissolution testing brought to the city by its new pharma resident, QUINTA-ANALYTICA.

28 October 2021

Artificial Intelligence and Pharma

World-leading companies such as QUINTA-ANALYTICA are embracing new technologies critical to revolutionizing research, attracting patients for trials, and reducing the speed of delivering results.

15 September 2021

Understanding drug distribution in the body

Administration of medication requires a thorough understanding of how and when it moves through the body, possible side effects or reactions, and the correct way to deliver it.

15 September 2021

Role of SMEs in Pharma

Are small and medium enterprises (SME’s) really a major driver of innovation in the pharmaceutical industry?

15 September 2021

Is mRNA the future of modern science?

As the prevalence of mRNA vaccines starts to take a solid foothold and their development rapidly into other medicinal areas hits new heights, finding the right pharma services company has become ever more a challenge.

15 September 2021

Is A Pilot Study Useful?

Before taking the plunge and carrying out a full-scale bioequivalence trial, it is typically desirable to dip your toe in the water, and often makes a lot of business sense, to first conduct a pilot trial.

15 September 2021

Clinical Trial Information System (CTIS)

Soon to become the single entry point for submitting clinical trial information in the EU, we present the Clinical Trial Information System (CTIS).

15 September 2021

Case Study: Analytical Method Validation

Whatever size your firm, it's essential to deliver on client expectations.

29 July 2021

Assessment of Bioequivalence

Nothing short of complex, and requiring highly intricate detail to conduct, the assessment of bioequivalence is a critical component in getting any new drugs to market.

29 July 2021

The Role of Quality Assurance

Across the pharma world, the alignment to guidelines and rules set out by the regulatory authorities must be not only met but exceeded in order to deliver success.

29 July 2021

The Importance of Human Relations

As an employer of hundreds of professionals, QUINTA-ANALYTICA takes staff engagement, motivation, and culture incredibly seriously.

29 July 2021

DeepMind AI Research Openly Available

The information that has been unlocked is vast, and indeed is being hailed as one of the most important datasets since the mapping of the Human Genome.

29 July 2021

CPhI Nitrosamines Impurities Forum 2021

It's clear to see the continued dominance of the Nitrosamines topic, and the impact the stringent rules and regulations are having on the industry.

30 June 2021

Summer and Team Celebration

This week we celebrated our teams, getting back to normal, and the arrival of summer.

30 June 2021

Let’s Talk Nitrosamines

This week sees the pharma industry get together virtually once more as the CPhI Conferences Nitrosamine Impurities Forum 2021 gets underway.

30 June 2021

The Value of Generic Medicine

A generic drug contains the same chemical substance as a drug that was originally branded and protected by patents (now expired).

30 June 2021

Conducting Parallel Studies

Before a new medicine or biologic can be marketed, its sponsor must show, through adequate and well-controlled clinical experiments, that it is effective.

2 June 2021

EU Funding for Quinta’s Brno Lab

Quinta has received EU funding toward the construction of it's new research and development laboratory in Brno, Czech Republic.

31 May 2021

Quinta-Analytica Passes Inspection

Quinta-Analytica's facilities in our HQ in Prague and also at our newest lab in Brno passes the latest GMP inspection by the Czech State Institute for Drug Control, SUKL.

31 May 2021

Quinta-Analytica awarded EcoVadis medal

EcoVadis is the world’s most trusted provider of business sustainability ratings, and their sustainability scorecard ranked Quinta amongst the top companies assessed.

31 May 2021

QUINTA-ANALYTICA are growing!

We have been quietly working behind the scenes on our new state of the art, ultra-modern lab capable of handling even the most highly potent drugs.

31 May 2021

Our New Electron Capture Detector

The team are pleased to announce delivery of our latest innovative piece of technology, allowing us to offer even greater selectivity and sensitivity to our clients and partners.

31 May 2021

Leveraging Crossover Trials

Crossover trials are clinical experiments in which participants are randomly assigned to a sequence of treatments wherein each participant serves as their own control in estimating effects.

3 May 2021

Monitoring Covid-19 Drugs

This presentation by the European Medicines Agency on Covid-19 drug testing monitoring.

22 April 2021

Quinta-Analytica and Greene Street Pharmaceuticals

Although an ocean may divide them, when it comes to choosing the right pharma services company, distance knows no bounds.

22 April 2021

Step Inside Clinical Testing

Offering a full range of clinical pharmacology solutions, bioavailability, interaction, bioequivalence, and much more, our purpose-built clinic allows for a huge range of trials.

22 April 2021

Step Inside Analytical R&D

If you’re developing volatile compounds, struggling with in-vitro testing, or looking for someone who has Franz diffusion cell expertise for your permeation studies, look no further.

22 April 2021

Fighting Antimicrobial Resistance

The world is fast running out of effective antibiotics as bacteria evolve to develop resistance to our taken-for-granted treatments.

17 March 2021

Fresh Website Update for 2021

The world moves forward, and so do we. Introducing our new look website.

17 March 2021

Step Inside Biopharmaceutical Analyses

An essential part of QUINTA-ANALYTICA’s service portfolio, its BioPharma team offers comprehensive support.

17 March 2021

Repositioning of Existing Drugs

The repositioning of existing drugs could be one of the keys to quickly seek effective drugs to reduce mortality and morbidity.

28 February 2021

Detecting Nitrosamine Contamination

Based on isotopically labeled standards, our customizable in-house detection methods are immediately available.

24 February 2021

Step Inside QC Project Coordination

Quality Control project management is an independent and essential function within the analytical operations department.

24 February 2021

Step Inside Pharmaceutical Analyses

Working both with methods provided by customers and those developed by our Analytical R&D teams, we offer a very flexible approach to meet your needs and be your true pharma partner.

24 February 2021

Step Inside Bioanalytical Department

Offering a comprehensive range of services including testing of the application form of drugs to guarantee compliance with exact specifications, our Bioanalytical laboratory is here to support all analytical aspects of your clinical and pre-clinical tests.

24 February 2021

Step Inside API Solutions

Our API Solutions truly remove complexity and bring true value to your developmental process.

24 February 2021

Bioequivalence in Pharmacokinetics

Offering extensive experience in the field of bioequivalence studies from project design and documentation, through clinical and bioanalytical work complete with full statistical clinical reports.

24 February 2021

Your world-class partner for preclinical studies

Offering a comprehensive end-to-end service in collaboration with a strategic partner, QUINTA-ANALYTICA can offer everything from preclinical development to toxicological (TK) studies.

24 February 2021

Wishing you a healthy, prosperous and exciting 2021!

Wishing our clients, colleagues, and friends all the very best for a healthy, prosperous, and exciting 2021!

24 February 2021

Why spray drying should be on every formulator’s mind

Spray-dried dispersions have some unique characteristics, and there are some important formulation and processing parameters to be considered when creating and incorporating ASDs into common dosage forms.

24 February 2021

USP 4 Flow-through Cell Dissolution

We're thrilled with the new USP Apparatus 4 (Flow-through Cell Apparatus) in our dissolution studies!

24 February 2021

Unique Medicines for Unique People

The pharmaceutical industry is seeing a shift toward personalized medicines, and it’s evolving to deliver this via some exciting new tools.

24 February 2021

Transparency for COVID-19 Vaccines

It should be a given fact for an industry so important to the world as pharmaceutical, but it’s still reassuring to see it announced publicly.

24 February 2021

The EMA Goes DIgital

Starting October 19th developers of human or veterinary medicines are instructed to use the EMA's new platform to request scientific advice.

24 February 2021

Test Your Starting Materials

To ensure patient safety its paramount to include the testing of starting materials in your overall production plan.‍

24 February 2021

Suspension of Generics

If your drug has been suspended, get in touch to see how we can help.

24 February 2021

Súkl (US-FDA) Certified 2019

Following a successful inspection in January 2019 by the State Institute for Drug Control in Prague, Quinta-Analytica is one of the first companies whose inspection report has been requested by the US FDA from the State Institute for Drug Control.

24 February 2021

Staying Safe This Holiday Season

Stay safe and celebrate this holiday season in good health!

24 February 2021

Quinta to attend BioJapan 2017

Our first appearance at BioJapan 2017, Asia's Premier Partnering Event for the Global Biotechnology Industry, on 11-13th October, 2017 in Pacifico Yokohama, Japan.

24 February 2021

Royal Society of Chemistry Releases 160 years of research

The Royal Society of Chemistry has announced that its full collection of research journals are now available.

24 February 2021

Ranitidine Medicines Suspended

The European Medicines Agency has recommended the suspension of all Ranitidine medicines in the EU.

24 February 2021

Prepare to package

Regardless of the study phase, magnitude of the trial, dosage forms, or trial design, getting your packaging and labeling right is critical.

24 February 2021

Plasma Protein Binding

QUINTA-ANALYTICA uses plasma protein equilibrium dialysis and LC-MS / MS to determine this critical binding for its partners.

24 February 2021

Over 90 FDA warning letters in 2019

Last year the FDA’s Center for Drug Evaluation and Research issued dozens warning letters for manufacturing issues to pharma companies outside the U.S. One country in particular received the highest amount.

24 February 2021

NLSDays 2019, Malmö Sweden

We love Sweden and we can't wait to be in beautiful Malmö attending NLSDays 2019 next week! Be sure to come and say hello if you'll be in town too.

24 February 2021

Nitrosamines Deadline Extension

The deadline has been extended to October 1st, but the countdown still continues.

24 February 2021

Nitrosamine Impurities – Have lessons been learnt?

Last week saw the publication of the European Medicines Agency report detailing what lessons can be learnt from the cases of unexpected N-nitrosamine impurities in sartans, which came to light mid-2018.

24 February 2021

Nitrosamine free development process

Thanks to the partnership of Chartwell Actives LLC and QUINTA-ANALYTICA we help ensure that your development process is nitrosamine free.

24 February 2021

Nitrosamine Deadline Extended AGAIN!

The European Medicines Agency just announced yet another extension for the testing of Nitrosamines contamination.

24 February 2021

Worried about Nitrosamine contamination?

Quinta-Analytica will be presenting its robust and versatile LC/MS/MS method during upcoming compliance meeting Nitrosamine Impurities organized by European Compliance Academy on February 18th, 2020 in Frankfurt.

24 February 2021

Quinta-Analytica’s New Website

We are very pleased to announce that our new website is live for the world!

24 February 2021

New Thermo Fisher Mass Spectrometer

When you need ultimate precision and flexibility, you need some rather special equipment!

24 February 2021

New Pharmaceutical Strategy for Europe

Members of the public, professionals, academia and researchers in the pharmaceutical industry are invited to contribute to the EU's pharma strategy.

24 February 2021

Like a drop in the ocean

QUINTA-ANALYTICA are proud to be one of the only companies in the world able to offer a significant LLOQ method of Tiotropium Bromide testing to our clients.

24 February 2021

Let’s (virtually) connect!

We’ll be attending the “Nitrosamines Impurities Forum (Americas)” next week. Will you join us?

24 February 2021

Introducing our new Head of Quality Assurance

We are exceptionally proud to welcome to our team, starting January, our new Head of Quality Assurance, Dr. Miroslav Janousek!

24 February 2021

Introducing our new Head of Clinical Department

We are excited and very proud to welcome Dr. Ondrej Palan to the Quinta team!

24 February 2021

First International Forum on Innovation and Research of Drugs for Cancer

Our CEO was a guest speaker at the First International Forum on Innovation and Research of Drugs for Cancer event in Tianjin, China

24 February 2021

Industry Events Impacted by COVID-19

Updated: Apr 1st | Pharma-related events which have been impacted by the spread of coronavisus disease COVID-19. Take a look at our event overview to see if it's affected your plans.

24 February 2021

IMI Stakeholder Forum 2020

The free-of-charge event strives to get the widest audience possible from health and medicines R&D together.

24 February 2021

How we indentify unknown impurities

With some of the best chemists in the industry using state of the art science and lab techniques, it now really is possible to identify the unidentified!

24 February 2021

How do YOU test the purity of your products?

Offering incredible accuracy and lightning-fast results, there is no better way to verify the identity of precursor materials used in the preparation of your drugdevelopment.

24 February 2021

High Performance Viscometer

Viscosity is a principal parameter when any flow measurements of fluids, such as liquids, semi-solids, gases, and even solids are made.

24 February 2021

Helping Our Friends

The FDA announced draft guidance this week to help facilitate the development of new animal drug products.

24 February 2021

Greene Street Pharmaceuticals

Greene Street Pharmaceuticals appoint QUINTA-ANALYTICA as exclusive API sourcing supplier.

24 February 2021

French Tax Credit System

Quinta have been granted approval into the French Tax Credit system.

24 February 2021

Quinta to attend CPHI/ICSE Frankfurt 2017

Quinta takes part as an exhibitor in the CPHI/ICSE Worldwide on 24-26th October, 2017 at Messe Frankfurt, Germany. Our stand location Nr. is 41N40 at the Analytical & Lab Services Zone.

24 February 2021

Fighting Counterfeit Medicines

Times of crisis overwhelmingly bring out the good in society, however they also see the fakes and counterfitters crawl out from their shadowy world.

24 February 2021

Ferric carboxymaltose methodology

A methodology we’re currently establishing to determine serum iron after administration of a colloidal form of iron (i.e. Ferric carboxymaltose) used in the treatment of anaemia.

24 February 2021

FDA Updates for conducting Clinical Trials during the #COVID-19 pandemic

Here’s what you need to know from the FDA’s updated guidance for clinical trials during the pandemic.

24 February 2021

FDA 2018 Bioanalytical Method Validation – A Practical Assessment

On the anniversary of the 2018 FDA Bioanalytical Method Validation Guidance publication, we assess the implications it's brought to the industry.

24 February 2021

euroPLX 69 London – Feb 2019

Join us at the upcoming euroPLX 69, in London, Feb 25th & 26th 2019. It is premiere partnering event for all aspects of Pharma, and we'll be there to discuss our five pillars of service.

24 February 2021

EMA and FDA Global Standards Collaboration

What happens when the US FDA, European Commission and European Medicines Agency all get together?

24 February 2021

Electrochemiluminescence Detection System

Electrochemiluminescence is a highly successful detection system that achieves clinical quality data in a variety of sample types.

24 February 2021

Eight current trends in the pharmaceutical industry

The pharmaceutical industry is dependent on research and development as much now as ever. Here we look at some of the of key areas that are currently catching the attention of our industry.

24 February 2021

Dr. Miroslav Ryska awarded Ioannes Marcus Mardi Medal

QUINTA-ANALYTICA's own Dr. Miroslav Ryska was just awarded the Ioannes Marcus Mardi Medal for Outstanding Achievement.

24 February 2021

It’s big, bold and booming. It’s CPhl China 2019.

Quinta Analytica once again attended CPhI in Shanghai, China a few weeks ago, and as usual it was an exciting and productive event. This year saw huge attendance numbers, and about 3,200 exhibitors from all around the world.

24 February 2021

CPhI Worldwide 2019, Frankfurt

CPhI Worldwide is the world's largest pharmaceutical exhibition, representing each stage of the supply chain from APIs, machinery and packaging to outsourcing and biopharmaceuticals.

24 February 2021

CPhI Shanghai China, 2019

Whether you are looking for sourcing new business or getting the latest market insight, this is your pharmaceutical platform in Asia.

24 February 2021

CPhI North America 2019

Quinta-Analytica will attend CPhI North America 2019 in Chicago as part of the pharmaceutical industry’s most established community. We hope to see you there!

24 February 2021

Announcing The CPhI ‘Festival of Pharma’

Following the cancellation of 2020 events worldwide, CPhI organizers have decided to transform the world’s largest pharma exhibition into a digital event.

24 February 2021

Quinta to participate in CPhI China 2018

Quinta-Analytica will attend prestigious event CPhI China 2018 held in Shanghai within 20th to 22nd June 2018. The purpose of our participation is to support business activities not only on Asian markets.

24 February 2021

CPhI 2020 Event Updates

CPhI has worked quickly to secure new dates for a handful of its 2020 events, and so far has confirmed new exhibition dates for CPhI Japan, CPhI South East Asia and CPhI North America.

24 February 2021

COVID-19 and the Pharma Industry

Working with key research projects Quinta are proud to be doing their part in the collective effort to rid the world of the most impactful issue ever seen.

24 February 2021

Clinical Trials in a Covid-19 World

This week saw the successful completion of the first bioequivalence study in the Czech Republic, and likely the first in Europe, since the Covid-19 outbreak began.

24 February 2021

Clinical trials focusing on the treatment of COVID-19

Are you conducting or planning a clinical trial focusing on the treatment of COVID-19? We are well placed to support you.

24 February 2021

Bring Manufacturing Back to the EU

Should drug manufacturing move back to Europe from Asia?

24 February 2021

Brexit and the Pharma Industry

With Brexit looming and the UK PM Boris Johnson saying last week that we must prepare for 'no deal', the pharma industry is on tenterhooks.

24 February 2021

Quinta to attend BioFit 2017

For the first time, Quinta-Analytica plans to present its services at BioFit, in November 28-29, 2017 Convention Centre, Strasbourg, France. BioFit is a platform in Europe for tech transfer and for sourcing early-stage innovations stemming from emerging biotech companies.

24 February 2021

BIO International Convention, Philadelphia, 2019

BIO International Convention celebrates the globally important innovations in biotech that start with one: one meeting, one theory, one trial, one breakthrough.

24 February 2021

Bio-Europe Spring 2019, Vienna

We'll be attending the Bio-Europe Spring 2019 conference in the beautiful city of Vienna, Austria. Meet us there!

24 February 2021

Quinta to attend Bio-Europe 2017

Quinta participates at the International Bio-Europe exhibition on 6-8th November, 2017 in CityCube Berlin, Germany.

24 February 2021

Quinta to attend BIO Convention 2018

Quinta-Analytica will attend the event BIO Convention 2018 held in Boston in 4th – 7th June 2018.

24 February 2021

New automated liquid handling system

The workhorse of laboratories across the world, the pipette, has a deep and wonderful history.

24 February 2021

Quinta-Analytica: 20 years of quality service

How did a small Czech Republic based pharma company hit the International stage?